Published in Proc Biol Sci on March 10, 2010
Modelling the evolution and spread of HIV immune escape mutants. PLoS Pathog (2010) 1.06
Modelling the spread of HIV immune escape mutants in a vaccinated population. PLoS Comput Biol (2011) 0.78
Natural selection among Eurasians at genomic regions associated with HIV-1 control. BMC Evol Biol (2011) 0.76
The global spread of HIV-1 subtype B epidemic. Infect Genet Evol (2016) 0.75
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science (1996) 18.38
Protection afforded by sickle-cell trait against subtertian malareal infection. Br Med J (1954) 11.13
The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med (1996) 10.62
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science (1999) 8.11
The influence of HLA genotype on AIDS. Annu Rev Med (2001) 7.77
Population-level HIV declines and behavioral risk avoidance in Uganda. Science (2004) 7.17
The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med (2006) 6.53
Changes in sexual behavior and a decline in HIV infection among young men in Thailand. N Engl J Med (1996) 5.77
Selective neutrality of 6PGD allozymes in E. coli and the effects of genetic background. Genetics (1980) 5.27
Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet (1998) 5.24
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med (2001) 4.98
HIV prevalence and trends in sub-Saharan Africa: no decline and large subregional differences. Lancet (2004) 4.76
Adaptation of HIV-1 to human leukocyte antigen class I. Nature (2009) 4.24
Advantage of rare HLA supertype in HIV disease progression. Nat Med (2003) 4.08
The impact of AIDS on gay male sexual behavior patterns in New York City. Am J Public Health (1987) 3.90
Improving projections at the country level: the UNAIDS Estimation and Projection Package 2005. Sex Transm Infect (2006) 3.58
HLA and AIDS: a cautionary tale. Trends Mol Med (2001) 3.51
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat Med (2003) 3.48
Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect Dis (2007) 2.83
Behaviour change in generalised HIV epidemics: impact of reducing cross-generational sex and delaying age at sexual debut. Sex Transm Infect (2007) 2.09
Natural selection and resistance to HIV. Nature (2001) 1.93
Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Multicenter AIDS Cohort Study Group. Am J Epidemiol (1989) 1.90
Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis (2000) 1.77
Molecular analysis of the beta-globin gene cluster in the Niokholo Mandenka population reveals a recent origin of the beta(S) Senegal mutation. Am J Hum Genet (2001) 1.73
Possible demographic consequences of AIDS in developing countries. Nature (1988) 1.57
Origins of HIV and the evolution of resistance to AIDS. Science (2006) 1.49
Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele. Proc Natl Acad Sci U S A (2003) 1.49
Evidence for population level declines in adult HIV prevalence in Kenya. Sex Transm Infect (2006) 1.46
The HLA A2/6802 supertype is associated with reduced risk of perinatal human immunodeficiency virus type 1 transmission. J Infect Dis (2000) 1.11
The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression. Clin Exp Immunol (2003) 0.95
HLA antigens associated with susceptibility/resistance to HIV-1 infection. Hum Immunol (1998) 0.91
HLA class I alleles associated with susceptibility or resistance to human immunodeficiency virus type 1 infection among a population in Chaco Province, Argentina. J Infect Dis (2000) 0.89
HLA-associated susceptibility to HIV-1 infection. Clin Exp Immunol (1992) 0.87
HLA disease association and protection in HIV infection among African Americans and Caucasians. Pathobiology (1991) 0.85
HIV-1 disease association with HLA-DQ antigens in African Americans and Caucasians. Pathobiology (1996) 0.79
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature (2002) 7.41
Public health. A sound rationale needed for phase III HIV-1 vaccine trials. Science (2004) 5.31
Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature (2008) 5.05
Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One (2008) 3.85
T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. Immunity (2004) 3.69
Common genetic variation and the control of HIV-1 in humans. PLoS Genet (2009) 3.68
Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J Virol (2009) 2.95
Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biol (2006) 2.81
Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor. J Virol (2004) 2.80
Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants. Nat Immunol (2005) 2.60
APOBEC3G inhibits elongation of HIV-1 reverse transcripts. PLoS Pathog (2008) 2.60
Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate. J Virol (2002) 2.43
Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys. J Virol (2003) 2.39
Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection. J Exp Med (2003) 2.37
Simian-human immunodeficiency virus escape from cytotoxic T-lymphocyte recognition at a structurally constrained epitope. J Virol (2003) 2.15
Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239. J Virol (2003) 2.14
The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia. Proc Natl Acad Sci U S A (2006) 2.13
Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS. J Virol (2003) 2.07
Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS. Proc Natl Acad Sci U S A (2004) 1.97
Dynamic coinfection with multiple viral subtypes in acute hepatitis C. J Infect Dis (2010) 1.75
The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4. Virology (2004) 1.72
A restatement of the natural science evidence base relevant to the control of bovine tuberculosis in Great Britain. Proc Biol Sci (2013) 1.69
Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion. Virology (2006) 1.66
Towards the endgame and beyond: complexities and challenges for the elimination of infectious diseases. Philos Trans R Soc Lond B Biol Sci (2013) 1.51
Copy number variation of KIR genes influences HIV-1 control. PLoS Biol (2011) 1.44
Loss of the N-linked glycosylation site at position 386 in the HIV envelope V4 region enhances macrophage tropism and is associated with dementia. Virology (2007) 1.43
Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. J Infect Dis (2010) 1.33
In vivo CD8+ T cell control of immunodeficiency virus infection in humans and macaques. Proc Natl Acad Sci U S A (2007) 1.33
Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model. J Virol (2010) 1.31
Increased loss of CCR5+ CD45RA- CD4+ T cells in CD8+ lymphocyte-depleted Simian immunodeficiency virus-infected rhesus monkeys. J Virol (2008) 1.30
When to initiate highly active antiretroviral therapy: a cohort approach. Am J Epidemiol (2003) 1.22
CCL3L1 and HIV/AIDS susceptibility. Nat Med (2009) 1.22
CD16+ monocytes exposed to HIV promote highly efficient viral replication upon differentiation into macrophages and interaction with T cells. Virology (2005) 1.22
Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy. J Virol (2002) 1.20
Human APOBEC3G-mediated editing can promote HIV-1 sequence diversification and accelerate adaptation to selective pressure. J Virol (2010) 1.15
Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote. Virology (2007) 1.09
Modelling the evolution and spread of HIV immune escape mutants. PLoS Pathog (2010) 1.06
Absence of xenotropic murine leukemia virus-related virus in blood cells of men at risk for and infected with HIV. AIDS (2010) 1.06
A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A. Hum Mol Genet (2013) 1.05
BSE - a wolf in sheep's clothing? Trends Microbiol (2002) 1.04
Repeated challenge with prion disease: the risk of infection and impact on incubation period. Proc Natl Acad Sci U S A (2003) 1.01
Bioinformatic prediction programs underestimate the frequency of CXCR4 usage by R5X4 HIV type 1 in brain and other tissues. AIDS Res Hum Retroviruses (2008) 1.00
Endogenous MOV10 inhibits the retrotransposition of endogenous retroelements but not the replication of exogenous retroviruses. Retrovirology (2012) 1.00
Quantification of the virus-host interaction in human T lymphotropic virus I infection. Retrovirology (2005) 0.99
Detection of HIV-1 p24 Gag in plasma by a nanoparticle-based bio-barcode-amplification method. Nanomedicine (Lond) (2008) 0.95
HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies. J Virol (2012) 0.94
Differential MHC class I expression in distinct leukocyte subsets. BMC Immunol (2011) 0.94
NFAT and IRF proteins regulate transcription of the anti-HIV gene, APOBEC3G. J Biol Chem (2010) 0.94
Hepatitis C virus genotype 1a NS5A pretreatment sequence variation and viral kinetics in African American and white patients. J Infect Dis (2005) 0.91
Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load. AIDS (2002) 0.91
Athena SWAN awards: Bridging the gender gap in UK science. Nature (2011) 0.90
Quantifying the risk from ovine BSE and the impact of control strategies. Proc Biol Sci (2007) 0.90
Cellular and humoral immune responses to a tetanus toxoid booster in perinatally HIV-1-infected children and adolescents receiving highly active antiretroviral therapy (HAART). Eur J Pediatr (2006) 0.89
Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression. AIDS (2002) 0.89
Insights into the evolution and emergence of a novel infectious disease. PLoS Comput Biol (2010) 0.89
Correlation between viral RNA levels but not immune responses in plasma and tissues of macaques with long-standing SIVmac251 infection. Virology (2005) 0.88
Emergence of cytotoxic T lymphocyte escape mutants following antiretroviral treatment suspension in rhesus macaques infected with SIVmac251. Virology (2003) 0.88
Structure and function of CC-chemokine receptor 5 homologues derived from representative primate species and subspecies of the taxonomic suborders Prosimii and Anthropoidea. J Virol (2003) 0.88
HAART-associated dyslipidemia varies by biogeographical ancestry in the multicenter AIDS cohort study. AIDS Res Hum Retroviruses (2013) 0.87
SHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant viruses. PLoS One (2011) 0.87
Identification of three NFAT binding motifs in the 5'-upstream region of the human CD3gamma gene that differentially bind NFATc1, NFATc2, and NF-kappa B p50. J Biol Chem (2002) 0.87
A real-time PCR-based method for determining the surface coverage of thiol-capped oligonucleotides bound onto gold nanoparticles. Nucleic Acids Res (2006) 0.86
Cytotoxic T-lymphocyte escape mutations identified by HLA association favor those which escape and revert rapidly. J Virol (2012) 0.85
High frequency of defective vpu compared with tat and rev genes in brain from patients with HIV type 1-associated dementia. AIDS Res Hum Retroviruses (2007) 0.85
A mathematical framework for estimating pathogen transmission fitness and inoculum size using data from a competitive mixtures animal model. PLoS Comput Biol (2011) 0.84
Genetic associations of variants in genes encoding HIV-dependency factors required for HIV-1 infection. J Infect Dis (2010) 0.84
What have we learnt from SARS? Philos Trans R Soc Lond B Biol Sci (2004) 0.84
The effect of intrinsic stochasticity on transmitted HIV drug resistance patterns. J Theor Biol (2009) 0.83
There is no safe dose of prions. PLoS One (2011) 0.82
Transcriptional regulation of the human CD3 gamma gene: the TATA-less CD3 gamma promoter functions via an initiator and contiguous Sp-binding elements. J Immunol (2005) 0.81
Integrating genealogical and dynamical modelling to infer escape and reversion rates in HIV epitopes. Proc Biol Sci (2013) 0.80
No evidence for competition between cytotoxic T-lymphocyte responses in HIV-1 infection. Proc Biol Sci (2009) 0.79
Modelling the spread of HIV immune escape mutants in a vaccinated population. PLoS Comput Biol (2011) 0.78
Human metapneumovirus infection in chimpanzees, United States. Emerg Infect Dis (2014) 0.76
Why was the 2009 influenza pandemic in England so small? PLoS One (2012) 0.75
Long-term nitrite inhalant exposure and cancer risk in MSM. AIDS (2017) 0.75
Retrospective. Norman L. Letvin (1949-2012). Science (2012) 0.75